Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company announced on Thursday that Phase 3 data results of diabetes treatment pill Tradjenta® (linagliptin) showed marked improvements in African-American blood sugar. The data were presented at the American Association of Clinical Endocrinologists (AACE) 21st annual Scientific and Clinical Congress, and to date, it is the only […]
-
Trending
Black Voters Matter Call Out TSU Trustees Removal -
Trending
Candace Owens Was On The Breakfast Club Wasting Time -
giving tuesday
Giving Tuesday: The Rich Tradition Of Black Philanthropy -
Indigenous Peoples' Day
Things You Wouldn't Have Without Native Americans -
op-ed
Taking A Stand Against Forced Motherhood -
women's history month
Erika Alexander Narrates New Audible Series 'Finding Tamika'